Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Class A Ordinary Shares, par value $0.0001 per share
-
Shares outstanding
-
73,766,892
-
Number of holders
-
87
-
Total 13F shares, excl. options
-
42,890,401
-
Shares change
-
+906,765
-
Total reported value, excl. options
-
$107,244,382
-
Value change
-
-$472,426
-
Put/Call ratio
-
55%
-
Number of buys
-
50
-
Number of sells
-
24
-
Price
-
$2.50
Institutional Holders of Zura Bio Ltd - Class A Ordinary Shares, par value $0.0001 per share (ZURA) as of Q4 2024
As of 31 Dec 2024 Zura Bio Ltd - Class A Ordinary Shares, par value $0.0001 per share (ZURA) had 87 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 42,890,401 shares of stock of the company.
Largest 10 holders included SUVRETTA CAPITAL MANAGEMENT, LLC, Deep Track Capital, LP, RA CAPITAL MANAGEMENT, L.P., GREAT POINT PARTNERS LLC, Pfizer Inc, BlackRock, Inc., JPMORGAN CHASE & CO, BRAIDWELL LP, Point72 Asset Management, L.P., and ADAR1 Capital Management, LLC.
This table shows 87 institutional shareholders of the security as of 31 Dec 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.